Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 72078-002

Norepinephrine Bitartrate Injection, USP is a medication that is used for intravenous infusion only, and requires dilution before use. Unused doses should be discarded and the medication should be protected from light. The medication is contained in a single-dose vial and each mL of the medication contains 1mg of norepinephrine base equivalent to 189 mg of norepinephrine tartrate. The medication also contains sodium chloride for isotonicity, sodium metabisulfite as an antioxidant and the vials have been displaced by nitrogen. The medication should not be used if it contains a precipitate, is pinkish or darker than a light yellow color. The medication should also be protected from contact with metals or oxidizing agents and be stored at room temperature. This medication is manufactured in India by a company called Mylan Institutional LLC and has the registered trademark Novaplus.*

Norepinephrine Bitartrate is a prescription-only injection for intravenous infusion containing 1mg of norepinephrine base in each ml, which is equivalent to 1.89mg of norepinephrine bitartrate, USP anhydrous basis. The medication is manufactured in India for Mylan Institutional LLC and carries a registered trademark of Vizient Inc. Patients should dilute the medication before use, discard unused portions, and protect it from light. The medication also contains sulfites.*